Domniki Gallou

Ms. Domniki Gallou


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2025 in Journal of Chromatography A
Verified
Journal Article
Closed access
DGDomniki Gallou
Domniki Gallou
OBOlga Begou
Olga Begou
Helen GikaHelen Gika
Helen Gika
VSVasiliki Sarli
Vasiliki Sarli
Ian WilsonIan Wilson
Ian Wilson
Georgios TheodoridisGeorgios Theodoridis
Georgios Theodoridis

20 May 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
DGDomniki Gallou
Domniki Gallou
Olga BegouOlga Begou
Olga Begou
Georgios TheodoridisGeorgios Theodoridis
Georgios Theodoridis
Helen GikaHelen Gika
Helen Gika
Background: Coenzyme Q10 and Alpha-lipoic acid are two essential antioxidants involved in numerous physiological processes, including cellular energy production and the mitigation of oxidative stress. Their accurate quantification is critical for understanding their biological roles and therapeutic potential. Herein, an RPLC-MS/MS method for the rapid and simultaneous determination of ubiquinone-10 (CoQ10), the reduced form ubiquinol-10 (CoQ10H2), and Alpha-lipoic acid (ALA) in human serum was developed and validated. Methods: Chromatographic separation was performed on a Waters ACQUITY UPLC HSS T3 column (2.1 mm × 150 mm, i.d. 1.7 μm). Detection was performed on a SCIEX Triple Quad 6500+ system, applying multiple reaction monitoring (MRM). Single-phase protein precipitation was selected as the sample preparation protocol, providing satisfactory recovery for the analytes. Results: The method was linear over the concentration of 53.8–613 ng/mL for CoQ10H2, 23.1–263 ng/mL for CoQ10 and 7.7–87.6 ng/mL for ALA. Intra- and inter-day accuracy was found to be between 81.8 and 109% and 84.4 to 106%, respectively, for all analytes, while intra- and inter-day precision was found to vary from 0.8% to 9.9% %RSD and 2.0% to 7.7% %RSD, respectively. A limit of quantitation (LOQ) of 4.2 ng/mL was found for CoQ10H2, 1.7 ng/mL for CoQ10 and 0.7 ng/mL for ALA. Conclusions: The developed LC-MS/MS method enables rapid, sensitive and simultaneous quantification of CoQ10H2, CoQ10, and ALA in human serum with satisfactory accuracy, precision and sensitivity. The method is suitable for bioanalytical applications and was successfully applied to the analysis of 10 real samples obtained from healthy volunteers.

19 August 2026 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
DGDomniki Gallou
Domniki Gallou
JMJaime Morillas-Armenta
Jaime Morillas-Armenta
MFMiguel Fernández-García
Miguel Fernández-García
BRBelén Fernández Requena
Belén Fernández Requena
SDSántiago Angulo Díaz-Parreño
Sántiago Angulo Díaz-Parreño
ALMA VILLASEÑORALMA VILLASEÑOR
ALMA VILLASEÑOR
Chronic kidney disease (CKD) has been associated with alterations in plasma-free aromatic amino acids (AAA)—tryptophan (Trp), phenylalanine (Phe), and tyrosine (Tyr)—and some downstream metabolites. However, AAA metabolism comprises a wider set of compounds, including microbiome-derived and sulfate-conjugated metabolites excreted in urine with potential biological implications. Alport syndrome (AS), a genetic condition defined by progressive renal impairment, frequently advances to CKD, suggesting that disturbances in AAA-related metabolism may also be relevant in this disorder. Nevertheless, a comprehensive quantitative method covering AAA-derived metabolites enabling an assessment of their implications in AS has not been established. Here, we introduce a novel method for the quantification of up to 43 AAA-derived metabolites in urine, including sulfated metabolites. The method is based on liquid chromatography coupled to tandem mass spectrometry and includes six deuterated internal standards to achieve reliable quantitation. A pooled healthy urine sample was characterized, and the method was validated in terms of linearity, matrix effect, accuracy, precision and sensitivity. The method was applied to urine samples from AS patients—with CKD and non-CKD—and controls. Significant alterations across groups in the concentrations of metabolites from Trp, Phe, and Tyr pathways were observed, including 4-OH-phenylacetic acid-O-sulfate. Notably, the urinary kynurenic acid (KYNA)/Trp ratio emerged as a potential indicator of renal function, showing a marked increase in AS patients with CKD, consistent with enhanced kynurenine pathway activation. Overall, this analytical platform represents a valuable tool for clinical research and for advancing the understanding of AAA-related metabolic dysregulation in renal diseases. Graphical Abstract

12 November 2026 in Scientific Data
Verified
Journal Article
Open access
PDF file
ALAntoine D. Lain
Antoine D. Lain
SGStephanie Go
Stephanie Go
AMAlisha Mahmud
Alisha Mahmud
SRShruti Rajendra
Shruti Rajendra
ACAinara Cano
Ainara Cano
JPJoram M. Posma
Joram M. Posma
We present here five biomedical, multi-entity corpora that can be used as benchmarks for named-entity recognition (NER), targeted to literature on metabolic syndrome. The CoDiet-Gold corpus contains annotations for 500 full-text publications and 348,406 annotations. It is divided into CoDiet-Gold-public (450 documents) and CoDiet-Gold-private (50 documents). Each document was independently annotated by two human experts, with disagreements fully adjudicated by a third expert. The CoDiet-Electrum corpus (2,998,273 annotations) contains 4,423 publications that were annotated using case-insensitive matching of the surface forms with punctuation ignored, found in CoDiet-Gold-public. Finally, for the same 4,423 documents, two fully machine-annotated corpora CoDiet-Bronze (2,938,738 annotations) and CoDiet-Silver (2,298,988 annotations), were created by utilising existing NER algorithms to annotate these. These corpora contain categories (organisms, disease, genes, proteins, metabolites) that add depth to existing corpora, as well as new categories that do not appear in other corpora (food, dietary methods, sample types, computational methods, study methodology, population characteristics, data types, and microbiome). These corpora and annotations are available at Zenodo in various forms ( https://doi.org/10.5281/zenodo.22097875 , https://doi.org/10.5281/zenodo.22097879 , and https://doi.org/10.5281/zenodo.22097881 ).